Skip to Main Content

Author Details

Damien Bolton
University of Melbourne
1988
386
45
PMIDPaper TitleJournal TitlePublished Year
37417458Intrarenal pressures during flexible ureteroscopy: an insight into safer endourology.BJU Int2024
35169274Social determinants of health: does socioeconomic status affect access to staging imaging for men with prostate cancer.Prostate Cancer Prostatic Dis2023
37842030Progressing Towards Same-Day Discharges After Robotic-Assisted Radical Prostatectomy; Safe and Cost Effective to Discharge Without Routine Blood Tests.Res Rep Urol2023
38057191Cost Effectiveness of Systemic Treatment Intensification for Metastatic Hormone-sensitive Prostate Cancer: Is Triplet Therapy Cost Effective?Eur Urol Oncol2023
37692142Aquablation in men with benign prostate hyperplasia: A systematic review and meta-analysis.Curr Urol2023
37818030PCNL in neurogenic bladder: A challenging population for both clinical management and analysis.BJUI Compass2023
37818025Pre-gerotal fat patch-A novel alternative to haemostatic agents during partial nephrectomy.BJUI Compass2023
353490743D printed patient-specific prostate cancer models to guide nerve-sparing robot-assisted radical prostatectomy: a systematic review.J Robot Surg2023
35689413Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer.BJU Int2023
36980741New Approaches to Targeting Epigenetic Regulation in Bladder Cancer.Cancers (Basel)2023
37309245Mechanism of urosepsis: relationship between intrarenal pressures and pyelovenous backflow.BJU Int2023
37099558Decade-long trends in prostate cancer biopsy grade groups and treatment within a population-based registry.BJU Int2023
370327615-alpha reductase inhibitors use in prostatic disease and beyond.Transl Androl Urol2023
36688575Benign ultrasound in a young adult with pT2 seminoma - beware the malignant potential of undescended testes.ANZ J Surg2023
36470068Global changes in bladder cancer mortality in the elderly.Cancer Epidemiol2023
36602577Investigating PSMA-PET/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance.World J Urol2023
36672291Dysfunctional Lipid Metabolism-The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer.Cancers (Basel)2023
36660860Laser eyewear: broadening the focus on eye safety in endourology.ANZ J Surg2023
36411180Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis.Urol Oncol2023
36156268Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review.Eur Urol Oncol2023
34623735Self-reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population-based registry.Psychooncology2022
35509478Impact of delay from transperineal biopsy to radical prostatectomy upon objective measures of cancer control.Asian J Urol2022
35802151Contributions to expenditure in endoscopic stone management: a costly process.Urolithiasis2022
35764368Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.J Immunother Cancer2022
35855555Novel germline mutations for active surveillance and imaging strategies in prostate cancer.Curr Opin Urol2022
35783586The impact of health-policy-driven subsidisation of prostate magnetic resonance imaging on transperineal prostate biopsy practice and outcomes.BJUI Compass2022
35681697PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow Up.Cancers (Basel)2022
36551620Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer-A Prospective Cohort Study.Cancers (Basel)2022
35869742New approaches to targeting epigenetic regulation in prostate cancer.Curr Opin Urol2022
36202722Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experience.J Med Imaging Radiat Sci2022
36167774A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry.Urol Oncol2022
36059632Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer.Front Oncol2022
35892882Novel Germline Mutations in a Cohort of Men with Familial Prostate Cancer.Cancers (Basel)2022
36123093PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.BMJ Open2022
35950036Cribriform pattern disease over-represented in pelvic lymph node metastases identified on <sup>68</sup>GA PSMA-PET/CT.BJUI Compass2022
36221211Clinical photography on personal mobile devices: a perspective on the issues facing surgeons.ANZ J Surg2022
35879832Active surveillance versus enzalutamide for low-risk prostate cancer - was it really a trial we needed?BJU Int2022
35224826A glass half-full: positive impacts of the COVID-19 pandemic on the delivery of public hospital urology care.BJU Int2022
34978202How Does Age Affect Urinary Continence following Robot-Assisted Radical Prostatectomy? A Prospective Multi-Institutional Study Using Independently Collected, Validated Questionnaires.J Urol2022
35305070Prostate-specific antigen testing testing in the modern era.ANZ J Surg2022
35300353Spindle cell tumours of the ureter: Operation or observation?Urol Case Rep2022
35083522Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.World J Urol2022
34750053Critical shortage in BCG immunotherapy: How did we get here and where will it take us?Urol Oncol2022
32548938Botox rechallenge-An additional tool in the management of an incompletely emptying bladder and inadequate overactive symptom control following sacral neuromodulation.Low Urin Tract Symptoms2021
35475295Which has more complications?-Shockwave lithotripsy versus endoscopic treatment of renal calculi with 1-year follow-up in an Australian population.BJUI Compass2021
33629384A pilot double-blind safety and feasibility randomized controlled trial of high-dose intravenous zinc in hospitalized COVID-19 patients.J Med Virol2021
33742473Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities.Br J Clin Pharmacol2021
33825293Utility of 3D printed abdominal aortic aneurysm phantoms: a systematic review.ANZ J Surg2021
33679268Zinc Preconditioning Provides Cytoprotection following Iodinated Contrast Media Exposure in In Vitro Models.Contrast Media Mol Imaging2021
33678516Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.Eur J Cancer2021
  • 1 - 50 of 386

Recommended Authors

Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 1
David C Johnson
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 3
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 0
Joseph Brito
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 3
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 2
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 2
Shiva M Nair
University of Western Ontario
Career Start Year 2005
Number of shared co-authors 0
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 3
Edward Rowe
Bristol Urological Institute, Southmead Hospital
Career Start Year 2004
Number of shared co-authors 7
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 10
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 7
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Declan Cahill
Royal Marsden Hospital NHS Trust
Career Start Year 1999
Number of shared co-authors 7
David Robert Siemens
Queen's University
Career Start Year 1996
Number of shared co-authors 3
Omer Acar
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 5
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 11
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 2
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Career Start Year 1989
Number of shared co-authors 7
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 2
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 8
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 9
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 8
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 8
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 8
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 24
Keong Tatt Foo
Rutgers Cancer Institute of New Jersey
Career Start Year 1975
Number of shared co-authors 0
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Career Start Year 1956
Number of shared co-authors 5

Collaborators

Graham G Giles
Co-authored papers 35
Declan G Murphy
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 32
Mark Frydenberg
Monash University
Co-authored papers 21
David Clouston
Co-authored papers 20
Anthony J Costello
Royal Melbourne Hospital
Co-authored papers 15
Heather Thorne
Peter MacCallum Cancer Centre
Co-authored papers 11
Renea A Taylor
Peter MacCallum Cancer Centre
Co-authored papers 9
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 8
Trung Pham
Stanford University
Co-authored papers 7
Roger L Milne
Co-authored papers 7
Gail P Risbridger
Biomedicine Discovery Institute, Monash University
Co-authored papers 7
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Co-authored papers 6
Arun A Azad
Peter MacCallum Cancer Centre
Co-authored papers 6
Ania Sliwinski
The Sir Peter MacCallum Department of Oncology University of Melbourne
Co-authored papers 5
John J McNeil
Co-authored papers 4
Melissa Papargiris
Biomedicine Discovery Institute, Monash University
Co-authored papers 4
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Co-authored papers 4
John J Mulvihill
University of Oklahoma
Co-authored papers 4
Ashutosh K Tewari
Co-authored papers 4
Rinaldo Bellomo
Royal Melbourne Hospital
Co-authored papers 3
Richard O'Sullivan
Co-authored papers 3
Gillian Mitchell
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Co-authored papers 3
Daniel J Park
The University of Melbourne
Co-authored papers 2
Carmel Murone
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Mun Sem Liew
The University of Melbourne
Co-authored papers 2
Anthony T Papenfuss
Co-authored papers 2
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 2
Neil E Fleshner
University of Toronto
Co-authored papers 2
Ali Tafreshi
University of Wollongong
Co-authored papers 2
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 1
Release 1.2